PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
September 24, 2025Biomimetics30 citationsOpen Access

Digital Twin Cognition: AI-Biomarker Integration in Biomimetic Neuropsychology

View Full Paper
EGEvgenia GkintoniCHConstantinos Halkiopoulos

Key Points

  • Multimodal integration approaches combine diverse data sources, enhancing the detection of cognitive conditions.
  • AI-driven deep learning models achieve superior pattern recognition, significantly outpacing traditional methods in efficacy.
  • Neuroimaging and digital phenotyping are crucial in individualized assessments, improving patient outcomes across various conditions.
  • Challenges remain in algorithm interpretability and external validation, necessitating further large-scale studies for clinical application.

Abstract

(1) Background: The convergence of digital twin technology, artificial intelligence, and multimodal biomarkers heralds a transformative era in neuropsychological assessment and intervention. Digital twin cognition represents an emerging paradigm that creates dynamic, personalized virtual models of individual cognitive systems, enabling continuous monitoring, predictive modeling, and precision interventions. This systematic review comprehensively examines the integration of AI-driven biomarkers within biomimetic neuropsychological frameworks to advance personalized cognitive health. (2) Methods: Following PRISMA 2020 guidelines, we conducted a systematic search across six major databases spanning medical, neuroscience, and computer science disciplines for literature published between 2014 and 2024. The review synthesized evidence addressing five research questions examining framework integration, predictive accuracy, clinical translation, algorithm effectiveness, and neuropsychological validity. (3) Results: Analysis revealed that multimodal integration approaches combining neuroimaging, physiological, behavioral, and digital phenotyping data substantially outperformed single-modality assessments. Deep learning architectures demonstrated superior pattern recognition capabilities, while traditional machine learning maintained advantages in interpretability and clinical implementation. Successful frameworks, particularly for neurodegenerative diseases and multiple sclerosis, achieved earlier detection, improved treatment personalization, and enhanced patient outcomes. However, significant challenges persist in algorithm interpretability, population generalizability, and the integration of healthcare systems. Critical analysis reveals that high-accuracy claims (85–95%) predominantly derive from small, homogeneous cohorts with limited external validation. Real-world performance in diverse clinical settings likely ranges 10–15% lower, emphasizing the need for large-scale, multi-site validation studies before clinical deployment. (4) Conclusions: Digital twin cognition establishes a new frontier in personalized neuropsychology, offering unprecedented opportunities for early detection, continuous monitoring, and adaptive interventions while requiring continued advancement in standardization, validation, and ethical frameworks.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Gkintoni et al. (2025) studied this question.

synapsesocial.com/papers/68d6d8768b2b6861e4c3e79ahttps://doi.org/10.3390/biomimetics10100640
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Digital twins in dementia: Early evidence and future directions for precision psychiatry2026
  2. 2Digital Twin-Based Framework for Early Prediction and Monitoring ofNeurological Disorders2026
  3. 3Digital Twins in Neurology Care: Evidence, Limitations, and a Path Forward2026
  4. 4Narrative Review of Digital Twins in the Health Domain: Development, Application, and Evidence Consolidation2026
  5. 5Multimodal Neuroimaging and AI Integration in Cognitive Disorders: Advances, Challenges, and Future Directions for Precision Medicine2026